LENSAR, Inc. (LNSR): R&D Expense
$5.62M
Year ended 2025-12-31
$5.32M
Trailing 12 months to 2026-06-30
-21.9%
3-year compound annual growth
-5.7%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.62M | +5.5% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $5.33M | -13.2% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $6.14M | -48.0% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $11.81M | -4.4% | 2024-03-04, From 2022-01-01 |
| 2021-12-31 | $12.36M | +63.6% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $7.55M | -0.2% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $7.57M | n/a | 2021-03-12, From 2019-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | 2025-12-31 | $5.62M | +5.5% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $11.13M | 0.0% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $2.38M | -31.0% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $3.37M | -33.6% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $17.02M | +19.0% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $20.84M | +2.4% |
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $7.73M | +72.2% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $14.96M | -15.4% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $14.61M | -18.8% |
Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗